12:00 AM
Jan 09, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ADXS-HPV: Preliminary Phase II data

Preliminary data from 31 evaluable women with recurrent or refractory cervical cancer in an Indian Phase II trial showed IV ADXS-HPV with or without cisplatin produced 1 complete response...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >